Nicotine patch and paroxetine for smoking cessation.
Abstract
Smokers (N = 224) were randomized to 1 of 3 groups: (a) transdermal system (TNS) + placebo; (b) TNS + paroxetine (20 mg); (c) TNS + paroxetine (40 mg). Assignment to treatment was double-blind. Nicotine patch (TNS) treatment was provided for 8 weeks; paroxetine or placebo was provided for 9 weeks. Abstinence rates at Weeks 4, 10, and 26 were as follows: (a) TNS + placebo: 45%, 36%, and 25%; (b) TNS + paroxetine (20 mg): 48%, 33%, and 21%; (c) TNS + paroxetine (40 mg): 57%, 39%, and 27%. The differences were not statistically significant. The combined treatment was more effective in reducing both craving and depression symptoms associated with smoking cessation. A subgroup analysis comparing compliant participants was also conducted. Abstinence rates at Weeks 4, 10, and 26 were as follows: (a) TNS + placebo: 46%, 35%, and 24%; (b) TNS + paroxetine (20 mg): 64%, 43%, and 33%; (c) TNS + paroxetine (40 mg): 74%, 51%, and 38%. The differences between paroxetine groups and placebo at Week 4 were statistically significant. Although paroxetine may add value to the current standard of care in excess of potential risk, more conclusive evidence is needed.
Cites (4)
- A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessationJorenby, Douglas E., Leischow, Scott J., Nides, Mitchell A., Rennard, Stephen I., Johnston, J. Andrew, Hughes, Arlene R., Smith, Stevens S., Muramoto, Myra L., Daughton, David M., Doan, Kimberli et al. · 1999 · New England Journal of Medicine
- Nortriptyline and Cognitive-Behavioral Therapy in the Treatment of Cigarette SmokingHall, Sharon M., Reus, Victor I., Muñoz, Ricardo F., Sees, Karen L., Humfleet, Gary, Hartz, Diane T., Frederick, Sydney, Triffleman, Elisa · 1998 · Archives of General Psychiatry
- Cigarette smoking and major depressionCovey, Lirio S., Glassman, Alexander H., Stetner, Fay · 1998 · Journal of Addictive Diseases
- Nicotine Replacement Therapy: What Has Been Accomplished - Can We Do Better?Benowitz, Neal L. · 1993 · Drugs
Cited by (18)
- Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health reportZiedonis, D., Hitsman, B., Beckham, J. C., Zvolensky, M., Adler, L. E., Audrain-McGovern, J., Breslau, N., Brown, R. A., George, T. P., Williams, J. et al. · 2008 · Nicotine & Tobacco Research
- Antidepressants for smoking cessationHughes, John R, Stead, Lindsay F, Lancaster, Tim · 2007 · Cochrane Database of Systematic Reviews
- Brain metabolic changes during cigarette cravingBrody, Arthur L., Mandelkern, Mark A., London, Edythe D., Childress, Anna Rose, Lee, Grace S., Bota, Robert G., Ho, Matthew L., Saxena, Sanjaya, Baxter, Lewis R., Madsen, Damian et al. · 2002 · Archives of General Psychiatry
- Antidepressants for smoking cessationHowes, Seth, Hartmann-Boyce, Jamie, Livingstone-Banks, Jonathan, Hong, Bosun, Lindson, Nicola · 2020 · Cochrane Database of Systematic Reviews
- Antidepressants for smoking cessationHughes, John R, Stead, Lindsay F, Hartmann-Boyce, Jamie, Cahill, Kate, Lancaster, Tim · 2014 · Cochrane Database of Systematic Reviews
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Nicotine patch and paroxetine for smoking cessation. https://app.cochat.ai/papers/10.1037//0022-006x.68.5.883
- The paper
- Killen, J. D., Fortmann, S. P., Schatzberg, A. F., Hayward, C., Sussman, L., Rothman, M., Strausberg, L., & Varady, A. (2000). Nicotine patch and paroxetine for smoking cessation. Journal of Consulting and Clinical Psychology. https://doi.org/10.1037//0022-006x.68.5.883
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.